Treatment of patients with relapsed/refractory multiple myeloma with lenalidomide and dexamethasone with or without bortezomib: prospective evaluation of the impact of cytogenetic abnormalities and of previous therapies
Dimopoulos, M A, Kastritis, E, Christoulas, D, Migkou, M, Gavriatopoulou, M, Gkotzamanidou, M, Iakovaki, M, Matsouka, C, Mparmparoussi, D, Roussou, MVolume:
24
Year:
2010
Language:
english
Pages:
10
DOI:
10.1038/leu.2010.175
File:
PDF, 473 KB
english, 2010